<DOC>
	<DOCNO>NCT00107081</DOCNO>
	<brief_summary>The purpose study determine whether , child cancer present fever severe chemotherapy-induced neutropenia low risk medical complication , oral antibiotic outpatient set initial phase intravenous antibiotic in-hospital observation 8 22 hour , inferior safety efficacy compare continue intravenous antibiotic give in-hospital .</brief_summary>
	<brief_title>Low-risk Fever Neutropenia Children With Cancer : Safety Efficacy Oral Antibiotics Outpatient Setting</brief_title>
	<detailed_description>Details antimicrobial therapy - At presentation FN ( fever neutropenia ) initial inpatient observation period 8 22 hour , empirical intravenous broad-spectrum antibiotic give . Type dosage choose treat physician . - Patients randomize continued intravenous antibiotic continue antibiotic . - Patients randomized oral antibiotic receive combination oral ciprofloxacin ( 25 30 mg/kg/day , top dose 1500 mg/day ) plus oral amoxicillin ( 65 80 mg/kg/day , top dose 2250 mg/day ) , give two dos per day . - In group , study give guideline ( certain situation ) rule ( situation ) change stop antibiotic . Details clinical laboratory control - During antibiotic therapy , patient see daily , either inpatient outpatient accord randomization . Complete blood count perform least every second day . - After stop antibiotic therapy resolution severe neutropenia ( applicable ) , patient see every day , complete blood count . - Patients randomized outpatient management possibility contact time day ( night ) pediatric oncologist case problem , order discus necessity emergency control and/or rehospitalization .</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Chemotherapy malignancy Severe neutropenia ( absolute neutrophil count ≤ 0.5x10E9/L ) Fever ( axillary temperature ≥ 38.5°C ≥ 38.0°C ≥ 2 hour ) Able swallow oral medication Written inform consent patient and/or parent Status post myeloablative chemotherapy Diagnosis : acute myeloid leukemia , Bcell acute lymphoblastic leukemia , Bcell NonHodgkin lymphoma Bone marrow involvement malignancy ≥ 25 % Any comorbidity require hospitalization : [ 1 ] mean arterial blood pressure &lt; 50 mmHg ( 10 year ) / &lt; 60 mmHg ( old 10 year ) ; [ 2 ] oxygen saturation &lt; 94 % room air ; [ 3 ] radiologically define pneumonia ; [ 4 ] focal bacterial infection ; [ 5 ] blood culture take presentation report positive reassessment ; [ 6 ] need inpatient treatment observation due reason , judge physician charge Ever shake chill Ever axillary temperature ≥ 39.5°C Antibacterial treatment presentation fever neutropenia ( except prevention Pneumocystis jiroveci [ formerly P. carinii ] pneumonia ) Modification de novo institution prophylaxis P. jiroveci pneumonia Modification de novo institution therapy GCSF GMCSF . Allergy ciprofloxacin and/or amoxicillin Serum creatinine level upper limit normal range</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>child</keyword>
	<keyword>oral antibiotic</keyword>
	<keyword>outpatient treatment</keyword>
	<keyword>fever neutropenia</keyword>
</DOC>